RecruitingNCT05734378

Prognosis of Cerebral Small Vessel Disease

Prognosis of Cerebral Small Vessel Disease - a Prospective Cohort Study (PRO-SVD)


Sponsor

Insel Gruppe AG, University Hospital Bern

Enrollment

900 participants

Start Date

Dec 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Prognosis of small vessel disease (SVD) depends on the underlying type of SVD and index manifestation. The aim of this prospective, observational cohort study is to determine the risk of different outcome events among patients with SVD according to the type of index presentation.


Eligibility

Min Age: 16 Years

Inclusion Criteria3

  • Hypertensive deep perforator arteriolopathy (DPA), clinically symptomatic with either ICH, ischaemic stroke, cognitive impairment or severe radiological manifestation (Fazekas ≥II)
  • Cerebral amyloid angiopathy (CAA according to modified Boston or Edinburgh criteria), clinically symptomatic with either ICH (including cSAH), amyloid spells, cognitive impairment or severe radiological manifestation (CMB≥2)
  • Other SVD (i.e. CADASIL or other sporadic or genetic SVD)

Exclusion Criteria2

  • Life expectancy of \<6 months due to not-SVD related causes (i.e. cancer)
  • Patient is unlikely to attend follow-up visits

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Department of Neurology, Inselspital Bern University Hospital

Bern, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05734378


Related Trials